Management Credibility Analysis
Upcoming Catalysts
Verified event feedCompany profile
No description available
- Chief executive
- Not disclosed
- Headquarters
- 3310 WEST END AVENUE, SUITE 700, NASHVILLE, TN
- Founded
- Not disclosed
📈 Company Timeline
Healthcare Realty Trust Incorporated securities registration filing
Healthcare Realty Trust Incorporated filed a registration or prospectus document concerning securities.
Healthcare Realty Trust Incorporated reported Another company event
Healthcare Realty Trust Incorporated filed an 8-K covering another company event, supporting financial statements or exhibits.
Healthcare Realty Trust Incorporated filed Form 10-Q
Healthcare Realty Trust Incorporated submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
Healthcare Realty Trust Incorporated reported Operating or financial results
Healthcare Realty Trust Incorporated filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.
Healthcare Realty Trust Incorporated reported Shareholder voting results
Healthcare Realty Trust Incorporated filed an 8-K covering shareholder voting results.
Capital Structure & Financial Position
Financial strength and liquidity analysisSource: SEC EDGAR company facts (opens in a new tab) Balance sheet dated
Peer Comparison - Real Estate
| Company | Price | Market Cap |
|---|---|---|
| WELL - Welltower Inc. |
$235.98
Yahoo Finance |
$170.08B |
| PLD - Prologis, Inc. |
$128.69
Yahoo Finance |
$122.01B |
| BN - Brookfield Corporation |
$37.54
Yahoo Finance |
$92.00B |
| AMT - American Tower Corporation |
$180.61
Yahoo Finance |
$84.16B |
| BAM - Brookfield Asset Management Ltd. |
$45.93
Yahoo Finance |
$73.36B |
📋 Corporate Actions
Recent and upcoming corporate eventsFinancials
Financial statements and key metrics analysis| Quarter | Revenue (USD) | Operating income | Net income | Diluted EPS (USD) | Filed |
|---|---|---|---|---|---|
| Q2 2026 | $8.03M | Unavailable | −$43.51M | −$0.13 | 10-Q · 30 Jul 2026 |
| Q1 2026 | $7.70M | Unavailable | −$56,000 | $0.00 | 10-Q · 1 May 2026 |
| Q4 2025 | $7.96M | Unavailable | $10.98M | Unavailable | 10-K · 13 Feb 2026 |
| Q3 2025 | $6.89M | Unavailable | −$57.74M | −$0.17 | 10-Q · 31 Oct 2025 |
| Q2 2025 | $6.98M | Unavailable | −$157.85M | −$0.45 | 10-Q · 1 Aug 2025 |
| Q1 2025 | $6.39M | Unavailable | −$44.87M | −$0.13 | 10-Q · 1 May 2025 |
Analyst Consensus
Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 14.00–24.00 Ratings are third-party opinions, not advice.
💰 Upcoming Dividends
Next dividend paymentsGuidance Evolution
💼 Director Transactions
Recent insider activityTop Shareholders
Source: Nasdaq institutional holdings (opens in a new tab) Observed · 18 hours ago